Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Companyâ€™s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-05 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
21/10/26	SEK 0.1924	+0.31%	1,106,095
20/10/26	SEK 0.1918	-1.74%	521,202
19/10/26	SEK 0.1952	+4.61%	962,307
16/10/26	SEK 0.1866	-2.30%	1,992,481
15/10/26	SEK 0.1910	-4.50%	1,291,393

Delayed Quote Nasdaq Stockholm

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Acarix AB

Company calendar

Market Closed - Nasdaq Stockholm 17:00:00 21/10/2026 BST			5-day change	1st Jan Change
0.1924 ^SEK	+0.31%		-3.80%	-28.21%

10-19	Acarix Wins Saudi Regulatory Nod for Coronary Artery Disease Detection Device	MT
09-24	25 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW

Market Cap	239M 24.13M 21.5M 19.91M 18.01M 33.94M 2.28B 34.34M 93.65M 1.2B 90.51M 88.63M 3.81B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	239M 24.13M 21.5M 19.91M 18.01M 33.94M 2.28B 34.34M 93.65M 1.2B 90.51M 88.63M 3.81B	EV / Sales 2026 *	17x	EV / Sales 2027 *	7.46x
Free-Float	89.13%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Nasdaq Stockholm	ACARIX	Delayed
OTC Markets	ACIXF	Delayed
Deutsche Boerse AG	7AC	Delayed
CBOE		Real-time
CBOE		Real-time

10-19	Acarix Wins Saudi Regulatory Nod for Coronary Artery Disease Detection Device	MT
09-24	25 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
09-17	Nine stocks have so far today hit new 52-week lows on the Stockholm stock exchange	FW
09-11	Acarix Publishes Peer-Reviewed Study Confirming CADScor System Diagnoses Heart Failure With Fewer False Positives Than Standard Blood Test	CI
08-13	Acarix AB, Q2 2026 Earnings Call, Aug 13, 2026
08-13	Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-13	Calendar for Thursday, August 13	FW
08-10	Acarix Receives Regulatory Approval For The CADScor System In The UAE	CI
08-10	Acarix Receives UAE Clearance for Point-of-Care Diagnostic Aid	MT
06-17	Acarix AB Announces Directorate Appointments	CI
06-16	Acarix AB Announces That Marlou Janssen-Counott Declines Re-Election as A Member of the Board of Directors	CI
06-12	Calendar Monday June 15 - Friday June 19	FW
05-21	Acarix AB, Q1 2026 Earnings Call, May 18, 2026

Acarix AB Share Price

Stocks

ACARIX

SE0009268717

Advanced Medical Equipment & Technology

Valuation: Acarix AB

Chart: Acarix AB

Latest news: Acarix AB

Last Transcript: Acarix AB

Analysts' recommendations: Acarix AB

Press Releases: Acarix AB

Quotes and Performance

Price Extremes

Managers and Directors: Acarix AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

10-19	Acarix : receives Regulatory Approval in Saudi Arabia.	PU
10-08	Acarix Provides Update on RHTP and Saudi Arabia Regulatory Process	AQ
09-14	Acarix: Seismocardiography gains further validation in heart failure	AQ
09-11	Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test	AQ
08-17	Acarix (Q2 Review): Laying the groundwork	AQ

1 day	+0.31%
1 week	-3.80%
Current month	-0.72%
1 month	-4.75%
3 months	-21.63%
6 months	-34.45%
Current year	-28.21%

1 week	0.18	0.2
1 month	0.18	0.24
Current year	0.18	0.33
1 year	0.18	0.34
3 years	0.17	0.6
5 years	0.17	1.47
10 years	0.17	26.8

Manager	Title	Age	Since
Aamir Mahmood CEO	Chief Executive Officer	-	31/01/2024
Christian Lindholm CEO	Chief Executive Officer	62	22/02/2018

Director	Title	Age	Since
Louise Janssen-Counotte BRD	Director/Board Member	61	31/12/2019
Kenneth Nelson BRD	Director/Board Member	52	13/05/2024
Tony Das BRD	Director/Board Member	-	13/05/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACARIX AB	+0.31%	-3.80%	-35.22%	-15.61%	24.13M
THERMO FISHER SCIENTIFIC, INC.	+0.97%	+3.09%	+24.38%	+49.46%	257B
DANAHER CORPORATION	+4.29%	+4.08%	+5.93%	+13.62%	164B
INTUITIVE SURGICAL, INC.	-2.26%	+1.88%	-7.48%	+60.40%	151B
BOSTON SCIENTIFIC CORPORATION	-2.35%	+3.51%	-55.45%	-11.07%	64.51B
SIEMENS HEALTHINEERS AG	+0.65%	+4.09%	-14.18%	-9.33%	52.1B
VEEVA SYSTEMS INC.	+0.59%	+7.80%	+10.60%	+59.96%	51.9B
EDWARDS LIFESCIENCES CORPORATION	+0.12%	+2.26%	+16.29%	+27.23%	50.95B
AGILENT TECHNOLOGIES, INC.	+2.74%	+2.16%	+22.01%	+62.73%	50.11B
WATERS CORPORATION	+3.31%	+4.78%	+30.99%	+80.36%	44.95B
Average	+0.84%	+2.83%	-0.21%	+31.78%	88.68B
Weighted average by Cap.	+0.92%	+3.70%	+6.38%	+38.48%

	2026 *	2027 *
Net sales	14M 1.42M 1.26M 1.17M 1.06M 1.99M 134M 2.01M 5.49M 70.2M 5.31M 5.2M 224M	32M 3.24M 2.88M 2.67M 2.42M 4.55M 305M 4.6M 12.56M 160M 12.14M 11.88M 511M
Net income	-30.8M -3.11M -2.77M -2.57M -2.32M -4.38M -294M -4.43M -12.09M -154M -11.68M -11.44M -492M	-15.3M -1.55M -1.38M -1.28M -1.15M -2.18M -146M -2.2M -6M -76.72M -5.8M -5.68M -244M
Net Debt	-	-